Oncoclinicas do Brasil (ONCO3) — Working Capital to Net Assets Ratio
Oncoclinicas do Brasil (ONCO3) has a Working Capital to Net Assets ratio of 27.9% as of September 2025. Working capital of R$334.03 Million (current assets of R$3.07 Billion minus current liabilities of R$2.73 Billion) is measured against net assets of R$1.20 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of Oncoclinicas do Brasil to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Oncoclinicas do Brasil Working Capital to Net Assets (2013–2024)
This chart shows how Oncoclinicas do Brasil's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 27.9%, reflecting working capital of R$334.03 Million against net assets of R$1.20 Billion BRL. See defensive interval ratio of Oncoclinicas do Brasil to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Oncoclinicas do Brasil (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Oncoclinicas do Brasil from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Oncoclinicas do Brasil.
| Year | WC/NA Ratio | Working Capital (BRL) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 65.3% | R$2.21 Billion | R$3.38 Billion | R$4.66 Billion | R$2.45 Billion | ▲ +17.2 pp |
| 2023 | 48.1% | R$1.29 Billion | R$2.68 Billion | R$3.11 Billion | R$1.82 Billion | ▲ +12.3 pp |
| 2022 | 35.8% | R$943.55 Million | R$2.63 Billion | R$2.83 Billion | R$1.88 Billion | ▼ -37.1 pp |
| 2021 | 72.9% | R$1.68 Billion | R$2.30 Billion | R$2.87 Billion | R$1.19 Billion | ▲ +13.3 pp |
| 2020 | 59.6% | R$406.05 Million | R$681.17 Million | R$1.43 Billion | R$1.02 Billion | ▲ +49.3 pp |
| 2019 | 10.3% | R$67.39 Million | R$656.37 Million | R$983.45 Million | R$916.05 Million | ▼ -25.0 pp |
| 2018 | 35.3% | R$165.79 Million | R$470.12 Million | R$613.27 Million | R$447.49 Million | ▲ +61.8 pp |
| 2017 | -26.6% | R$-61.75 Million | R$232.44 Million | R$348.31 Million | R$410.06 Million | ▼ -59.6 pp |
| 2016 | 33.1% | R$80.88 Million | R$244.56 Million | R$299.47 Million | R$218.59 Million | ▼ -7.0 pp |
| 2015 | 40.1% | R$78.58 Million | R$195.87 Million | R$235.66 Million | R$157.08 Million | ▲ +337.3 pp |
| 2014 | -297.2% | R$-67.65 Million | R$22.77 Million | R$141.57 Million | R$209.22 Million | ▼ -358.2 pp |
| 2013 | 61.0% | R$29.38 Million | R$48.16 Million | R$115.17 Million | R$85.79 Million | — |